Wednesday, July 8, 2026

pharma · Total Laryngectomy · Breast Cancer · ATOS

ATOSSA THERAPEUTICS

Athos Therapeutics is a pharma organization headquartered in Torrance, USA. It trades on NYSE under ticker ATOS. Primary therapeutic focus areas include Total Laryngectomy, Breast Cancer, Breast Cancer, Preneoplastic Con

Torrance, USA HQ
2019 Founded
36 Employees
Public company Type
ATOS · NYSE Ticker
Company details
Status
Public
HQ
Torrance, USA
Founded
2019
Employees
36
Programs
10
Drugs
5
Patents
8
Clinical program

ForeCYTE Breast Aspirator

Phase 3 · other · Breast Cancer, Preneoplastic Conditions, BRCA

ForeCYTE Breast Aspirator for Breast Cancer, Preneoplastic Conditions, BRCA is a Phase 3 program (other) at ATOSSA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Internal code GCP005

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
ATOSSA THERAPEUTICS, INC.
Phase
Phase 3
Modality
other
Indication
Breast Cancer, Preneoplastic Conditions, BRCA
Status
terminated
Trials
1

Clinical trials